About this ingredient
MK-677 (Ibutamoren) is an investigational compound that stimulates the release of growth hormone. Unlike injectable growth hormone, it is an orally active, non-peptide growth hormone secretagogue. Research has examined its effects on growth hormone, IGF-1, body composition, appetite and metabolic parameters.
In a study of healthy older adults, MK-677 increased pulsatile growth hormone secretion and IGF-1 concentrations. The same study reported an increase in fasting glucose at the higher studied exposure.
Another clinical study in obese men found increased GH, IGF-1 and fat-free mass, while oral glucose testing showed impaired glucose homeostasis.
The FDA has highlighted safety concerns surrounding ibutamoren, including increased appetite, water retention, fatigue, muscle pain and potential alterations in glucose metabolism and insulin sensitivity. FDA has also identified potential concern regarding congestive heart failure in certain patients; a randomized trial in people recovering from hip fracture was terminated early because of a potential heart-failure safety signa




